novoprotein

Novoprotein (Suzhou Novoprotein Scientific / 苏州近岸蛋白质科技股份有限公司) is a Chinese biotechnology company specializing in recombinant protein preparation and related life-science reagents and contract research services. Its catalog spans mRNA vaccine raw materials, cytokines and growth factors, Matrigel and culture media, reference and bispecific antibodies, cell lines, target proteins, and viral research products serving drug discovery, cell therapy, and diagnostics customers. It was surfaced as a portfolio company of Qiming Venture Partners and added to the API Evangelist network. As a B2B reagent supplier it publishes no public developer API, API documentation, or developer portal.

novoprotein is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Recombinant Proteins, and Antibodies.

🌐 Visit website 📡 Source on GitHub
7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyLife SciencesRecombinant ProteinsAntibodiesReagentsCell TherapyDrug Discovery

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 7.7/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/novoprotein: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Novoprotein Domain Security

TLSv1.2 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: novoprotein
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/novoprotein.png
name: novoprotein
description: Novoprotein (Suzhou Novoprotein Scientific / 苏州近岸蛋白质科技股份有限公司) is a Chinese biotechnology company specializing
  in recombinant protein preparation and related life-science reagents and contract research services. Its catalog spans mRNA
  vaccine raw materials, cytokines and growth factors, Matrigel and culture media, reference and bispecific antibodies, cell
  lines, target proteins, and viral research products serving drug discovery, cell therapy, and diagnostics customers. It
  was surfaced as a portfolio company of Qiming Venture Partners and added to the API Evangelist network. As a B2B reagent
  supplier it publishes no public developer API, API documentation, or developer portal.
url: https://raw.githubusercontent.com/api-evangelist/novoprotein/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Life Sciences
- Recombinant Proteins
- Antibodies
- Reagents
- Cell Therapy
- Drug Discovery
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/novoprotein-domain-security.yml
- type: Website
  url: https://novoprotein.com.cn
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1